Precigen (PGEN) Return on Sales (2012 - 2026)

Precigen (PGEN) has 15 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• On a quarterly basis, Return on Sales rose 40.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.06%, a 21.0% increase from a year earlier, with the FY2025 full-year figure at 0.26%, changed N/A from the prior year.
• Return on Sales for Q1 2026 stood at 0.0%, up from 0.03% in the prior quarter.
• Over the last five years, Return on Sales for PGEN reached as high as 0.51% in Q2 2023 and fell as low as 239.78% in Q3 2024.
• Historically, Return on Sales has averaged 16.14% across 5 years, with a median of 0.03% in 2025.
• Across the five-year window, Return on Sales slumped 133 bps in 2024 and soared 23823 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.13% in 2022, then jumped by 305 bps to 0.51% in 2023, then plunged by 110 bps to 0.05% in 2024, then soared by 44 bps to 0.03% in 2025, then soared by 89 bps to 0.0% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.0% in Q1 2026, 0.03% in Q4 2025, and 1.55% in Q3 2025.